Contrasting Wellness Center USA (OTCMKTS:WCUI) & Lipella Pharmaceuticals (NASDAQ:LIPO)

Lipella Pharmaceuticals (NASDAQ:LIPO) and Wellness Center USA (OTCMKTS:WCUI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Insider and Institutional Ownership

74.3% of Lipella Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.0% of Wellness Center USA shares are owned by institutional investors. 37.0% of Lipella Pharmaceuticals shares are owned by company insiders. Comparatively, 15.7% of Wellness Center USA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Lipella Pharmaceuticals and Wellness Center USA, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lipella Pharmaceuticals	0	0	1	0	3.00
Wellness Center USA	0	0	0	0	N/A

Lipella Pharmaceuticals presently has a consensus price target of $2.00, indicating a potential upside of 526.57%. Given Lipella Pharmaceuticals’ higher possible upside, equities research analysts plainly believe Lipella Pharmaceuticals is more favorable than Wellness Center USA.

Earnings and Valuation

This table compares Lipella Pharmaceuticals and Wellness Center USA”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lipella Pharmaceuticals	$450,000.00	5.67	-$4.62 million	($0.60)	-0.53
Wellness Center USA	$660,000.00	0.08	-$750,000.00	N/A	N/A

Wellness Center USA has higher revenue and earnings than Lipella Pharmaceuticals.

Risk & Volatility

Lipella Pharmaceuticals has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500. Comparatively, Wellness Center USA has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.

Profitability

This table compares Lipella Pharmaceuticals and Wellness Center USA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lipella Pharmaceuticals	-817.16%	-172.07%	-141.17%
Wellness Center USA	N/A	N/A	N/A

Summary

Wellness Center USA beats Lipella Pharmaceuticals on 6 of the 11 factors compared between the two stocks.

About Lipella Pharmaceuticals

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

About Wellness Center USA

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.